Case Control Study
Copyright ©The Author(s) 2025.
World J Psychiatry. May 19, 2025; 15(5): 103628
Published online May 19, 2025. doi: 10.5498/wjp.v15.i5.103628
Table 1 Comparison of clinical features of patients in different groups, mean ± SD/n (%)
Clinical feature
Total number of patients (n = 108)
Thyroid cancer group (n = 48)
Benign nodule group (n = 30)
Mental disorder group (n = 30)
χ2/F
P value
Age (years)56.27 ± 6.5156.67 ± 6.2556.17 ± 7.0655.76 ± 6.580.1830.833
Gender0.1580.924
Male50 (46.30)23 (47.92)13 (43.33)14 (46.67)
Female58 (53.70)25 (52.08)17 (56.67)16 (53.33)
BMI (kg/m2) 23.21 ± 3.4823.11 ± 3.5723.26 ± 3.6223.35 ± 3.290.0460.955
Smoking history24 (22.22)14 (29.17)6 (20.00)4 (13.33)2.7960.247
Drinking history32 (29.63)19 (39.58)7 (23.33)6 (20.00)4.1850.123
Duration of mental disorders (years)3.48 ± 0.623.54 ± 0.213.49 ± 0.323.41 ± 0.242.4400.092
FT3 (pmol/L)16.20 ± 4.6618.96 ± 2.5416.25 ± 5.3311.75 ± 2.8536.9790.000
FT4 (pmol/L)38.87 ± 20.2052.23 ± 18.4139.52 ± 12.3316.85 ± 2.6559.1050.000
TSH (mU/L)2.94 ± 0.472.96 ± 0.462.89 ± 0.542.94 ± 0.410.2060.814
TT3 (nmol/L)2.04 ± 0.282.03 ± 0.242.05 ± 0.282.04 ± 0.190.0650.937
TT4 (nmol/L)107.58 ± 21.31106.33 ± 22.41111.31 ± 19.63105.85 ± 21.360.6370.531
ALT (U/L)27.73 ± 10.8132.65 ± 11.5228.45 ± 7.6919.13 ± 6.3419.5550.000
AST (U/L)27.75 ± 5.3828.13 ± 5.6527.95 ± 4.9826.95 ± 5.410.4680.628
ALP (U/L)84.27 ± 22.4287.15 ± 21.7484.96 ± 22.1478.98 ± 23.541.2520.290
TBil (μmol/L)15.86 ± 5.6918.13 ± 5.5816.23 ± 4.1611.85 ± 5.1114.1510.000
TP (g/L)72.76 ± 5.7673.26 ± 6.3572.99 ± 5.1871.72 ± 5.340.6910.504
ALB (g/L)43.22 ± 5.8441.54 ± 6.9443.79 ± 5.2945.33 ± 3.184.3450.015
Cortisol (nmol/L)178.77 ± 28.43198.41 ± 16.98179.87 ± 14.13146.23 ± 24.1172.9760.000
NE (ng/L)277.50 ± 69.03326.85 ± 56.31249.85 ± 44.18226.17 ± 54.2539.4910.000
Ang II (ng/mL)18.89 ± 5.8423.68 ± 4.9815.79 ± 2.5414.32 ± 3.1564.5230.000
SOD (nU/mL)92.99 ± 22.9876.25 ± 6.2195.34 ± 6.41117.41 ± 27.5466.1660.000